Morgan Stanley Increasingly More Positive on Humana (HUM)
Get Alerts HUM Hot Sheet
Price: $363.86 -0.76%
Rating Summary:
15 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Rating Summary:
15 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Join SI Premium – FREE
Morgan Stanley analyst Michael Ha on Humana (NYSE: HUM): "Based on our proprietary Medicare Advantage benefits analysis, we now grow increasingly comfortable with $1b being enough cost savings/value creation to meet Humana’s unprecedented levels of plan value investments next
year. We believe $1b of Value Creation Plan will be enough to cover Humana's 2023 plan value investments – we estimate 2023 plan value investments translate to ~$791m of increased spend."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana (HUM) PT Raised to $471 at Guggenheim
- JPMorgan Downgrades Mankind Pharma Ltd (MANKIND:IN) to Neutral
- Humana (HUM) PT Raised to $390 at Baird
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share